Association between residual islet beta-cell function and achieving the target of time in range in inpatients with T2DM undergoing anti-diabetic treatment: an observation study.

Beta-cell function was associated with achieving the target of TIR and TAR. Stimulating insulin secretion or exogenous insulin treatment could not overcome the disadvantage of lower beta-cell function on glycemic control. This article is protected by copyright. All rights reserved.